NRAS and colorectal carcinoma: The prevalence of NRAS mutation is 3.9%, which is consistent with the range of 2.2%‐7% as reported in other studies.23, 24, 25 Some researchers suggested that NRAS was more common in older patients.10 However, we did not find a remarkable correlation between NRAS mutation and clinicopathological features of CRC.